Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.51 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.50 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.44 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.42 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.40 |
| ▸ | NAAA | Q02083 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | MC4R | P32245 | 1/20 | 0.40 |
| ▸ | MC5R | P33032 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1611043 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL1610204 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL1612447 | 0.98 | SIGMAR1 (0.50) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL1487677 | 0.94 | SIGMAR1 (0.53) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL133399 | 0.94 | SIGMAR1 (0.58) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL1610345 | 0.92 | SIGMAR1 (0.56) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL1610472 | 0.92 | SIGMAR1 (0.56) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL129049 | 0.92 | SIGMAR1 (0.56) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL27523237 | 0.91 | SIGMAR1 (0.54) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 | |
| SCHEMBL128560 | 0.88 | SIGMAR1 (0.59) | SIGMAR1CYP1A2HDAC1HDAC8CYP2A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | SUMITOMO CHEMICAL COMPANY LIMITED (JP) | 2011-04-14 | — | — | US | disclosed |
| EP-2248818-A1 | ORGANIC SEMICONDUCTOR MATERIAL | Sumitomo Chemical Company, Limited (JP) | 2010-11-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110087034-A1 | Organic Semiconductor Material | OR10J3, TST, OR51E2 | SIGMAR1 223/4885CYP1A2 125/4885HDAC1 2752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.